|
An unexpected nitrosamine product of oclacitinib: Synthesis, structural elucidation, ADMET profiling and preliminary toxicological assessment-Pub
|
|
4
|
202
|
August 26, 2026
|
|
Theoretical evaluation of NDSRIs
|
|
11
|
390
|
August 26, 2026
|
|
Approaching the Solid-Phase Reaction Limit: Nitrosation of 4-Phenylpiperidine Hydrochloride in Dense Slurries-Pub
|
|
0
|
68
|
August 20, 2026
|
|
From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals-Pub
|
|
0
|
114
|
August 19, 2026
|
|
A Rapid and Sensitive LC–MS/MS Method for Quantification of NDSRI in Melatonin Drug Product via Controlled In Situ Formation-Pub
|
|
0
|
99
|
August 14, 2026
|
|
N-Nitroso Metamizole Impurity C
|
|
5
|
517
|
August 11, 2026
|
|
An Analytical Quality by Design-guided method development for the quantification of N-nitroso-fluoxetine to support mitigation strategies for a fluoxetine drug product-Pub
|
|
2
|
227
|
August 8, 2026
|
|
🛑 N-nitroso Ticagrelor
|
|
32
|
4307
|
August 8, 2026
|
|
Nitrosamine Control Strategy for Products within the Scope of ICH S9
|
|
5
|
317
|
August 7, 2026
|
|
N-Nitroso Desmethyl Tramadol - Standard
|
|
3
|
230
|
July 27, 2026
|
|
Complex versus simple N-nitrosamines: Comprehensive genotoxicity and in silico carcinogenicity assessment toward future testing paradigms -Pub
|
|
8
|
743
|
July 25, 2026
|
|
Which Molecule Is Involved in the Nitrosation Reaction of Pharmaceuticals: NO or NO 2 ? -Pub
|
|
3
|
270
|
July 24, 2026
|
|
Trace-level LC–MS/MS quantification of two nitrosamine impurities formed from terazosin-related impurities in pharmaceutical products and greenness assessment-Pub
|
|
2
|
209
|
July 15, 2026
|
|
In Vitro Metabolism Study of NDSRIs
|
|
4
|
425
|
July 9, 2026
|
|
Research on Nitrosamines in Complex Preparations
|
|
4
|
387
|
July 8, 2026
|
|
Another Prazosin recall linked to N-nitroso-prazosin impurity C raises renewed concern for the finished product
|
|
10
|
860
|
July 7, 2026
|
|
Analytical Challenges in Quantifier Ion Selection Due to Mass Error Variability
|
|
7
|
340
|
July 2, 2026
|
|
NDSRI growth with respect to age
|
|
12
|
570
|
June 25, 2026
|
|
Why is NMEA associated with Amphotericin B? (Appendix 1 March 2026 Update)
|
|
3
|
291
|
June 19, 2026
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
20
|
5636
|
June 17, 2026
|
|
Application of read-across to data-poor N-nitrosamines: N-nitroso-ulifloxacin, a case study-Pub
|
|
1
|
161
|
June 16, 2026
|
|
Finasteride NDSRI
|
|
2
|
182
|
June 15, 2026
|
|
EDTA-Related Nitrosamine Impurities: Two Critical Pain Points in Pharma R&D
|
|
5
|
509
|
June 1, 2026
|
|
Understanding In Vitro Nitrosamine Formation During Sample Preparation
|
|
4
|
320
|
June 1, 2026
|
|
Solution stability of NDSRI
|
|
8
|
416
|
May 25, 2026
|
|
Nitrite in Amines
|
|
14
|
1069
|
May 21, 2026
|
|
Development and Validation of a Trace-Level LC–MS/MS Method for the Determination of N-Nitroso Clozapine in Clozapine Drug Substance -Pub
|
|
0
|
116
|
May 20, 2026
|
|
Strategies for Mitigating In-Source Fragmentation in NDSRI Analysis using LC-MS
|
|
4
|
2986
|
May 20, 2026
|
|
UHPLC-MS/MS Single Run Quantification Method for Simultaneous Determination of Triazolopyrazine and N-Nitroso-Triazolopyrazine in Sitagliptin; Risk Assessment, Scavenger-Based Mitigation, and Stress Stability Study -Pub
|
|
0
|
106
|
May 20, 2026
|
|
Simultaneous Determination of Duloxetine and N-Nitroso-Duloxetine in Reactor Cleaning Solvent Samples by LC–HRMS: Formation, Quantitation, and Green -Pub
|
|
0
|
138
|
May 20, 2026
|